ArticleFrontiers in immunology2026
Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients.
Qi Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.